Tianyin Pharmaceutical Inc Co Company Profile (NYSEMKT:TPI)

About Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)

Tianyin Pharmaceutical Inc Co logoTianyin Pharmaceutical Co., Inc. is a pharmaceutical company. Through the Company's indirect wholly owned subsidiary, Chengdu Tianyin Pharmaceutical Co., Ltd., it is engaged in the development, manufacturing, marketing and sales of patented biopharmaceutical medicines, branded generics, modernized traditional Chinese medicines and other pharmaceuticals in China. As of June 30, 2013, the Company is manufacturing a range of 58 products approved by the China Food and Drug Administration (CFDA), 24 of which are listed in the National Medical Reimbursement List (NMRL) and 10 are listed in the Essential Drug List (EDL) of the China. The Company's medicines are used in the therapeutic areas of internal medicines, gynecology, hepatology, otolaryngology, urology, neurology, dermatology, pediatrics, gastroenterology and orthopedics. The Company markets its products through regional distributors, as well as directly to the hospitals, clinics and pharmacies.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NYSEMKT:TPI
  • CUSIP: N/A
  • Web: N/A
Average Prices:
  • 50 Day Moving Avg: $0.16
  • 200 Day Moving Avg: $0.16
  • 52 Week Range: $0.12 - $0.18
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Profitability:
  • Net Margins: -31.28%
  • Return on Equity: -5.17%
  • Return on Assets: -4.91%
 

Frequently Asked Questions for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)

What is Tianyin Pharmaceutical Inc Co's stock symbol?

Tianyin Pharmaceutical Inc Co trades on the New York Stock Exchange (NYSE)MKT under the ticker symbol "TPI."

Where is Tianyin Pharmaceutical Inc Co's stock going? Where will Tianyin Pharmaceutical Inc Co's stock price be in 2017?

1 equities research analysts have issued twelve-month price targets for Tianyin Pharmaceutical Inc Co's stock. Their forecasts range from $23.00 to $23.00. On average, they expect Tianyin Pharmaceutical Inc Co's stock price to reach $23.00 in the next year. View Analyst Ratings for Tianyin Pharmaceutical Inc Co.

Who are some of Tianyin Pharmaceutical Inc Co's key competitors?

Who are Tianyin Pharmaceutical Inc Co's key executives?

Tianyin Pharmaceutical Inc Co's management team includes the folowing people:

  • Guoqing Jiang, Chairman of the Board, President, Chief Executive Officer, Acting Chief Financial Officer
  • Tao Yang, Chief Operating Officer
  • Xintao You, Chief Technology Officer
  • Daqiao Zhang, Vice President - Marketing and Sales
  • Jianping Hou Ph.D., Independent Director
  • Zhan Yong, Independent Director
  • Zunjian Zhang Ph.D., Independent Director

How do I buy Tianyin Pharmaceutical Inc Co stock?

Shares of Tianyin Pharmaceutical Inc Co can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tianyin Pharmaceutical Inc Co's stock price today?

One share of Tianyin Pharmaceutical Inc Co stock can currently be purchased for approximately $0.16.


MarketBeat Community Rating for Tianyin Pharmaceutical Inc Co (NYSEMKT TPI)
Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  14 (Vote Outperform)
Underperform Votes:  13 (Vote Underperform)
Total Votes:  27
MarketBeat's community ratings are surveys of what our community members think about Tianyin Pharmaceutical Inc Co and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $23.00

Analysts' Ratings History for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)
Show:
DateFirmActionRatingPrice TargetDetails
1/17/2017Roth CapitalInitiated CoverageBuy$23.00View Rating Details
(Data available from 9/25/2015 forward)

Earnings

Earnings History for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)
Earnings by Quarter for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)
Earnings History by Quarter for Tianyin Pharmaceutical Inc Co (NYSEMKT TPI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/14/2013Q1$0.05$15.97 million$14.75 millionViewN/AView Earnings Details
9/27/2013Q313$0.07ViewN/AView Earnings Details
2/14/2013Q2 2013$0.06$18.20 million$17.60 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)
Insider Trades by Quarter for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)
Insider Trades by Quarter for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/3/2014Guoqing JiangCEOBuy23,725$0.68$16,133.00View SEC Filing  
5/28/2014James Jiayuan TongCFOBuy5,000$0.68$3,400.00View SEC Filing  
3/11/2014James Jiayuan TongCFOBuy3,000$1.07$3,210.00View SEC Filing  
6/26/2013James Jiayuan TongCFOBuy8,600$0.49$4,214.00View SEC Filing  
3/28/2013James Jiayuan TongCFOBuy56,500$0.08$4,520.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)
Latest Headlines for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)
Source:
DateHeadline
americanbankingnews.com logoTianyin Pharmaceutical (TPI) Receiving Somewhat Critical Media Coverage, Analysis Shows
www.americanbankingnews.com - May 3 at 8:56 AM
americanbankingnews.com logoTianyin Pharmaceutical (TPI) Receives Daily Media Impact Rating of -0.20
www.americanbankingnews.com - April 18 at 8:34 AM
247wallst.com logo8 IPO Hopefuls for Week of July 18
247wallst.com - July 18 at 9:25 AM
seekingalpha.com logoNYSE prepares to delist Tianyin Pharma over failure to file financials
seekingalpha.com - May 7 at 2:51 PM
finance.yahoo.com logoTianyin Pharmaceutical Co., Inc. (TPI)
finance.yahoo.com - February 18 at 12:54 PM
feeds.benzinga.com logoWorst Performing Industries For February 3, 2016
feeds.benzinga.com - February 3 at 12:33 PM
biz.yahoo.com logoTianyin Pharmaceutical Co., Inc.
biz.yahoo.com - January 21 at 12:33 PM
biz.yahoo.com logoTIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K/A, Notice of Delisting or Failure to Satisfy a Continued Listing
biz.yahoo.com - January 11 at 4:39 PM
finance.yahoo.com logoTPI Received Acceptance Letter From NYSE MKT Regarding its Plan of Compliance with Continued Listing Requirements
finance.yahoo.com - January 11 at 4:05 PM
biz.yahoo.com logoTIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K/A, Other Events
biz.yahoo.com - December 23 at 2:27 PM
finance.yahoo.com logoTIANYIN PHARMACEUTICAL CO., INC. Financials
finance.yahoo.com - December 8 at 1:15 PM
biz.yahoo.com logoTIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Ru
biz.yahoo.com - December 2 at 4:06 PM
finance.yahoo.com logoTPI Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements
finance.yahoo.com - December 2 at 4:05 PM
biz.yahoo.com logoTIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Other Events
biz.yahoo.com - October 16 at 10:28 AM
biz.yahoo.com logoTIANYIN PHARMACEUTICAL CO., INC. Files SEC form 10-Q/A, Quarterly Report
biz.yahoo.com - August 20 at 10:58 AM
biz.yahoo.com logoTIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Non-Reliance on Previous Financials, Audits or Interim Review
biz.yahoo.com - August 11 at 6:21 AM
finance.yahoo.com logoTPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements
finance.yahoo.com - July 30 at 4:05 PM

Social

This page was last updated on 9/25/2017 by MarketBeat.com Staff